🎯 New speaker alert: Jennifer Wargo (MD Anderson Cancer Center, US) will share cutting-edge advances in precision, genetically targeted cancer therapies at the THPT Conference. 📍 Leuven | 🗓️ 10–12 Dec | #THPT25 🔗 Early bird registration deadline: 29 October vibbio.tech/THPT25

The Tumor Heterogeneity, Plasticity & Therapy Conference welcomes Céline Vallot (@institutcurie.bsky.social) to share her research on epigenomic evolution of breast cancers at single-cell resolution. 📍 Leuven | 📅 10–12 Dec | #THPT25 ⏳ Early bird registration deadline: 29 October vibbio.tech/THPT25

🎉 Not 1, but 2 prizes! Huge congrats to our team members for their outstanding achievements at the 7th Research Day on Tumor Immunology and Immunotherapy! 🏆 Alicia Gordun Pero–Poster Prize 🎤 Pauline Bardet–Selected Talk Prize We’re proud to see their hard work and research being recognized 👏

At the Tumor Heterogeneity, Plasticity and Therapy Conference (#THPT25) in Leuven from 10–12 December, Eduard Batlle from IRB Barcelona will show how the tumor microenvironment can facilitate immune evasion and metastasis. Abstract deadline: 8th of October vibbio.tech/THPT25

The Laoui Lab will be well represented at the Tumor Heterogeneity, Plasticity and Therapy (3rd edition) conference #THPT25! Join us to hear more about therapy resistence in #cancer from Anna Obenauf @obenaufa.bsky.social Submit your abstract by the 8th of October on vibbio.tech/THPT25

🚨 New publication! In a collaborative effort led by Etherna, we reveal how two optimized LNPs trigger distinct IgG2a vs IgG1 phenotypes. This opens the door to tuning LNP design for tailored immune responses in mRNA vaccines & beyond. advanced.onlinelibrary.wiley.com/doi/10.1002/...

Watching students grow into independent scientists is the best part of this job. Huge congrats to my first PhD student @matekiss.bsky.social stating his onw lab!

Our new paper is out: Tumors don’t just reprogram monocytes locally. We show in a mouse model that the systemic impact of a tumor can alter the epigenome of peripheral monocytes, repressing IFN-responsive regulatory elements and priming pro-tumor gene programs.

I am grateful to co-lead authors Laszlo Halasz and Eva Hadadi, and everyone involved from the labs of Jo Van Ginderachter, Laszlo Nagy, and Damya Laoui (@laouimmunology.bsky.social‬).

Day 3 at #INCI25 @movahedilab.bsky.social presented some fantastic images of brain immune niches as well as their recently published work in @cp-immunity.bsky.social on microglia replacement therapy. After the break, Christoph Scheiermann reminded us how much our day-night cycle impact immunity

Last presenter of the day at #INCI25, Michele De Palma presented some impressive results exploiting cytokine-armed dendritic cell progenitors as cancer therapy in anti-PD1 refractory lung cancer. Now up to enjoy our boat tour in the beautiful Bruges and socialize with our fellow-scientists!

We finish the Cell Therapy session at #INCI25 with two top speakers. First, Tobias Weiss provided an overview of the next-generation therapies for glioblastoma from antibody-cytokine fusion proteins to cytokine-expressing CAR-T cells and exploiting macrophages as drug delivery platform.

After presenting my poster at #INCI25 about the potential of CD40 agonist to enhance anti tumor immunity of tumor-derived cDCs, the session started with an excellent talk by Gabriele Bergers about the key role of the diva’s of endothelial cells, the high endothelial venules in anti-tumor immunity!

Day 2 at #INCI25 started with a great neuro-immuno crosstalk session. As selected abstract, VIB Alumni Ilaria Decimo showed us her exciting work uncovering that TAMs can promote neuronal growth and can be exploited to restore functional motor recovery in a mouse model of spinal cord injury!

Another great talk by Pablo Vargas @leukomotion.bsky.social at #INCI25! His strategy, question the lack of hereditary immunodeficiencies linked to leukocyte motility! The DNA damage protein ATM came out as unexpected candidate with ATM inhibition reducing leukocyte motility in 3D matrices

After some lunch and the first poster session, we are ready for the afternoon session with my fellow conference reporters to report back on the most interesting talks at #INCI25. So follow @tommasoscolaro.bsky.social and @vibtrainconf.bsky.social to learn about the newest hot topics!

We finished our first extremely interesting morning session at #INCI25! As selected abstract, @gretamattavelli.bsky.social from the @riedel-lab.bsky.social was the last to present her PhD work on the role of lymph nodes in metastasis formation before the break!

Ready for a full day of interesting talks at the Immune Niches in Cancer and Inflammation #INCI25 conference in the beautiful Bruges 🙂 @viblifesciences.bsky.social

Very proud of Pauline Bardet, PhD student in our lab for not only presenting her work on SEPARATE-Seq as a new method to characterise our novel orthotopic lung cancer model at the VIB seminar, but also winning the prize for best presentation👏 @viblifesciences.bsky.social #scRNAseq #cancerresearch

The Immune Niches in Cancer and Inflammation conference #INCI25 is almost here ⏰Registration closes April 23rd Don't miss this chance to hear more from Tobias Weiss who will share his insights into novel immunotherapeutic strategies for glioblastoma treatment! 🔗 vibbio.tech/INCI25

The final registration deadline for #INCI25 is approaching! Register before the 23rd of April to join us in Bruges and learn more about leukocyte dynamics in immune pathologies from Pablo Vargas from the INEM in Paris. Register now at vibbio.tech/INCI25 @leukomotion.bsky.social

Interested in hearing more about how our 🕐internal clock🕐 can influence anti-tumor immunity? Christoph Scheiermann will explain all about it at the Immune Niches in Cancer and Inflammation conference #INCI25 ! Don’t miss the early bird registration! 🚨Deadline: 26th of March vibbio.tech/INCI25

🚨Early Bird registration deadline for #INCI25 is approaching Register before the 26th of March and join us in Bruges to hear more from Miriam Merad on the regulation of #TLS formation and maintenance in #cancer and discuss the role of #DCs in TLS 😃 @miriammerad.bsky.social vibbio.tech/INCI25

📢 Check out the first 🎙️ interview for our #WomenInScience campaign! 🎉 Damya Laoui shared her insights on the challenges women face in science, career paths, and breaking barriers. 💡🔬 The interview was led by Ewa Oleszycka, diving deep into these important topics! 👩🏼‍🔬

At the #INCI25, a full session is dedicated to #celltherapy. As dendritic cell aficionados, we are excited to hear more about engineered dendritic cells from expert in the field Michele De Palma from EPFL! Join us and submit your abstract! Abstract deadline: 28th of February vibbio.tech/INCI25

The Laoui Lab will be well represented at the Immune Niches in Cancer and Inflammation conference #INCI25! Join us to hear more from expert in the field of vascular niches in #cancer Gabrielle Bergers @bergerslab.bsky.social Submit your abstract by the 28th of February on vibbio.tech/INCI25

Today is #womaninscience day! For all the ladies out there that doubt if science is something for them, yes it is! #proudoftheteam @vubrussel @viblifesciences.bsky.social

Both #Cancer #Research starter packs are now completely full! ~300 researchers, oncologists, students, postdocs, patient advocates, and organizations supporting cancer research 🧪🔬⚕️ I hope you'll find these useful to build our community here Pack 1: go.bsky.app/FEoaJMc Pack 2: go.bsky.app/6EcjWNA

Excited to share our latest work in @NatureComms ! 🎉 LNP-formulated mRNA encoding IL-21, IL-7, & 4-1BB drives systemic anti-tumor immunity—spotlight on cDC2s! 👀 Led by Ahmed Hamouda, in collaboration with @eTheRNA_engine & @bruno_de_geest. Read here: rdcu.be/d2zQ7